āĻšā§āĻŽBAVA âĸ VIE
add
Bavarian Nordic A/S
⧍⧧.ā§Šā§ŽâŦ
⧍ āĻŽā§, ā§Ģ:ā§Ģā§Ļ:ā§Ļā§Ŧ PM GMT +⧍ · EUR · VIE · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
⧍⧧.ā§Ļ⧍âŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
⧍⧧.⧍ā§âŦ - ⧍⧧.ā§Ŧā§ŠâŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§§ā§.⧝⧍âŦ - ā§Šā§¯.ā§Ēā§ŠâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧧⧝ā§Ļ.ā§Šā§Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
⧍ā§.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
CPH
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(DKK) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ⧍ā§Ļ⧝.ā§Šā§¯Â āĻā§ | -ā§§ā§Ē.ā§Ēā§Ē% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ē⧍.ā§Ŧā§ŠÂ āĻā§ | -ā§Šā§¯.⧍ā§Ŧ% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§ā§.ā§Ļā§ŽÂ āĻā§ | -ā§§ā§Ē.ā§Ē⧝% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§Šā§Ŧ.ā§Žā§§ | -ā§Ļ.ā§Ļā§Ģ% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ⧝.⧝ā§Ļ | -ā§§ā§Ģ.ā§Šā§Ž% |
EBITDA | ā§¯ā§Š.ā§Ŧā§Ŧ āĻā§ | -ā§.ā§Ģ⧍% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | -ā§Š.ā§§ā§Ž% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(DKK) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ⧍⧧ā§.ā§Ģā§Â āĻā§ | ā§§ā§Ŧ.ā§Ēā§Ē% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§§ā§Ē.ā§Ēā§§āĻļāĻ¤Â āĻā§ | ā§Ļ.ā§Šā§% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧍⧝⧝.ā§ā§ŠÂ āĻā§ | -⧍ā§Ģ.ā§Šā§¨% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§ā§§.ā§Ēā§§āĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§.ā§Žā§Ŧ āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ļ.ā§§ā§Ē | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ē.ā§Ģ⧝% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ž.ā§Ģā§Ļ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(DKK) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§ā§.ā§Ļā§ŽÂ āĻā§ | -ā§§ā§Ē.ā§Ē⧝% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ⧝ā§Ģ.ā§Ģā§Ē āĻā§ | ā§Ŧā§Š.⧧⧝% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Šā§¨.ā§Ģā§Ē āĻā§ | -⧧⧍ā§Ŧ.ā§Ēā§Š% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§§.ā§Ŧā§¯Â āĻā§ | -ā§¨ā§¨ā§Ž.ā§Ļā§Ŧ% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ā§Ŧ⧍.ā§Ŧā§ŽÂ āĻā§ | ā§Ēā§Ļ.ā§Žā§Ē% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| -ā§Ģā§Ē.ā§Ģā§Ģ āĻā§ | -ā§§ā§ā§Ģ.ā§Ģ⧝% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in KvistgÃĨrd, Denmark and ThÃļrishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, California, as well as offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors and virus-like particles in its research and development. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ āĻā§āϞ, ⧧⧝⧝⧍
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§§,ā§Ŧā§Ļā§Ģ